Search from the table of contents of 2.5 million books
Advanced Search (Beta)
Home > Markers in cardiology: current and future clinical applications / > Ch. 6. Acute Coronary Syndromes: Pathophysiology, Clinical Presentation, and Initial Diagnostic Strategies
Markers in cardiology: current and future clinical applications / |
Adams, Jesse E.
Futura Pub. Co.,
Markers in cardiology: current and future clinical applications /
Ch. 6. Acute Coronary Syndromes: Pathophysiology, Clinical Presentation, and Initial Diagnostic Strategies
Authors

Jesse E. Adams III and Vickie A. Miracle

ARI Id

1675530292670_52756261

Access

Open/Free Access

Table of Contents of Book
Showing 1 to 20 of 20 entries
Chapters/HeadingsAuthor(s)PagesInfo
Ch. 1. Analytical Issues Affecting the Clinical Performance of Cardiac Troponin Assays
Alan H. B. Wu
Ch. 2. Prepare To Meet Your Markers: Making the Most out of Troponin I Degradation
Jason L. McDonough, Ralf Labugger and Jennifer E. Van Eyk
Ch. 3. Functional Sensitivity of Cardiac Troponin Assays and its Implications for Risk Stratification for Patients with Acute Coronary Syndromes
Kiang-Teck J. Yeo, Kelly S. Quinn-Hall and Stephanie W. Bateman /[et al.]
Ch. 4. Report on a Survey of Analytical and Clinical Characteristics of Commercial Cardiac Troponin Assays
Fred S. Apple, Jesse E. Adams III and Alan H. B. Wu /[et al.]
Ch. 5. The Current Assessment of Qualitative and Quantitative Point-of-Care Testing of Cardiac Markers
Roland Valdes, Jr. and Saeed A. Jortani
Ch. 6. Acute Coronary Syndromes: Pathophysiology, Clinical Presentation, and Initial Diagnostic Strategies
Jesse E. Adams III and Vickie A. Miracle
Ch. 7. WHO Criteria: Where Do We Go from Here?
Allan S. Jaffe
Ch. 8. An Integrated Diagnostic Approach to the Patient with Chest Pain
Robert L. Jesse and Michael C. Kontos
Ch. 9. The Use of Cardiac Markers for Therapeutic Decisions in Acute Coronary Syndromes
Michael P. Hudson, Britta U. Goldmann and E. Magnus Ohman
Ch. 10. The Evaluation of Acute Coronary Syndrome in the Emergency Department: The Impact of Cardiac Biomarkers and ST-Segment Trend Monitoring
David A. Grundy and W. Brian Gibler
Ch. 11. Cardiac Troponin T in Coronary Artery Disease: Where Do We Stand?
Evangelos Giannitsis, Britta Weidtmann and Margit Muller-Bardorff /[et al.]
Ch. 12. Creatine Kinase: A Marker for the Early Diagnosis of Acute Myocardial Infarction
Robert Fromm and Robert Roberts
Ch. 13. Fatty Acid Binding Protein as a Plasma Marker for the Early Assessment of Individuals with Acute Coronary Syndromes
Jan F. C. Glatz and Wim T. Hermens
Ch. 14. Oxidized Low-Density Lipoprotein and Malondialdehyde-Modified Low-Density Lipoprotein: Markers of Coronary Artery Disease
Paul Holvoet, Frans Van de Werf and Johan Vanhaecke /[et al.]
Ch. 15. High-Sensitivity C-Reactive Protein: A Novel Inflammatory Marker for Predicting the Risk of Coronary Artery Disease
Paul M. Ridker
Ch. 16. Nuclear Factor Kappa B: A Marker of Coronary Artery Disease Activity?
George K. Daniel, Richa Gupta and Jessica Gillespie /[et al.]
Ch. 17. The Use of Troponins to Detect Cardiac Injury after Cardiac and Noncardiac Surgery
Jose E. Adams III
Ch. 18. The Role of Cardiac Troponin Testing in Renal Disease
Fred S. Apple
Ch. 19. The Use of Cardiac Biomarkers for the Detection of Drug-Induced Myocardial Damage
Eugene H. Herman and V. J. Ferrans
Ch. 20. The Utility of Brain Natriuretic Peptides in Patients with Heart Failure and Coronary Artery Disease
Johannes Mair.
Chapters/HeadingsAuthor(s)PagesInfo
Showing 1 to 20 of 20 entries
Similar Books
Similar Chapters
Similar Thesis

Similar News

Similar Articles
Similar Article Headings